mlsanityData to 14 Oct 2026

ShEPhERD: Diffusing shape, electrostatics, and pharmacophores for bioisosteric drug design

arXiv 2411.04130 ↗First posted 22 Oct 2024q-bio.BM cs.LGcited by 13

Not on the map. Why?

Abstract (arXiv)

Engineering molecules to exhibit precise 3D intermolecular interactions with their environment forms the basis of chemical design. In ligand-based drug design, bioisosteric analogues of known bioactive hits are often identified by virtually screening chemical libraries with shape, electrostatic, and pharmacophore similarity scoring functions. We instead hypothesize that a generative model which learns the joint distribution over 3D molecular structures and their interaction profiles may facilitate 3D interaction-aware chemical design. We specifically design ShEPhERD, an SE(3)-equivariant diffusion model which jointly diffuses/denoises 3D molecular graphs and representations of their shapes, electrostatic potential surfaces, and (directional) pharmacophores to/from Gaussian noise. Inspired by traditional ligand discovery, we compose 3D similarity scoring functions to assess ShEPhERD's ability to conditionally generate novel molecules with desired interaction profiles. We demonstrate ShEPhERD's potential for impact via exemplary drug design tasks including natural product ligand hopping, protein-blind bioactive hit diversification, and bioisosteric fragment merging.

Key facts. Cited by 13 papers in the map (data through 14 Oct 2026). First posted on arXiv 22 Oct 2024.

Builds on

0 of 0 references.

No references here yet.

Built on by

Cited by year (2026 to 14 Oct)

Citing papers per year: 2025: 3; 2026: 10.

13 papers.

Sort:

By area:

Similar, not cited

Close in wording, no citation either way

  1. 2025Pharmacophore-Conditioned Diffusion Model for Ligand-Based De Novo Drug Design
  2. 2026SynLaD: Latent Diffusion for Generating Synthesizable Molecules Conditioned on 3D Pharmacophore Profiles
  3. 20233D Equivariant Diffusion for Target-Aware Molecule Generation and Affinity Prediction
  4. 2022Equivariant 3D-Conditional Diffusion Models for Molecular Linker Design
  5. 2022Structure-based Drug Design with Equivariant Diffusion Models
  6. 2024Diffusion Models in textitDe Novo Drug Design
  7. 20253DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery
  8. 2026Beyond Affinity: A Benchmark of 1D, 2D, and 3D Methods Reveals Critical Trade-offs in Structure-Based Drug Design